PL2849758T3 - Kompozycje zawierające kwas zoledronowy lub pokrewne związki do uśmierzania bólu zapalnego i stanów powiązanych - Google Patents

Kompozycje zawierające kwas zoledronowy lub pokrewne związki do uśmierzania bólu zapalnego i stanów powiązanych

Info

Publication number: PL2849758T3
Authority: PL; Poland
Prior art keywords: compositions; zoledronic acid; inflammatory pain; relieving inflammatory; related compounds
Prior art date: 2012-05-14

Application number

PL13791356T

Other languages

English (en)

Inventor

Herriot TABUTEAU

Original Assignee

Antecip Bioventures Ii Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-14

Filing date

2013-05-14

Publication date

2018-08-31

2013-05-14 Application filed by Antecip Bioventures Ii Llc filed Critical Antecip Bioventures Ii Llc

2018-08-31 Publication of PL2849758T3 publication Critical patent/PL2849758T3/pl

Links

206010065390 Inflammatory pain Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000000203 mixture Substances 0.000 title 1
XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 title 1
229960004276 zoledronic acid Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL13791356T 2012-05-14 2013-05-14 Kompozycje zawierające kwas zoledronowy lub pokrewne związki do uśmierzania bólu zapalnego i stanów powiązanych PL2849758T3 (pl)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US201261646538P	2012-05-14	2012-05-14
US201261647478P	2012-05-15	2012-05-15
US201261654383P	2012-06-01	2012-06-01
US201261654292P	2012-06-01	2012-06-01
US201261655541P	2012-06-05	2012-06-05
US201261655527P	2012-06-05	2012-06-05
US201361762225P	2013-02-07	2013-02-07
US201361764563P	2013-02-14	2013-02-14
US201361767647P	2013-02-21	2013-02-21
US201361767676P	2013-02-21	2013-02-21
US201361803721P	2013-03-20	2013-03-20
EP13791356.2A EP2849758B1 (en)	2012-05-14	2013-05-14	Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
PCT/US2013/040939 WO2013173330A1 (en)	2012-05-14	2013-05-14	Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions

Publications (1)

Publication Number	Publication Date
PL2849758T3 true PL2849758T3 (pl)	2018-08-31

Family

ID=49549077

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13791356T PL2849758T3 (pl)	2012-05-14	2013-05-14	Kompozycje zawierające kwas zoledronowy lub pokrewne związki do uśmierzania bólu zapalnego i stanów powiązanych

Country Status (21)

Country	Link
US (5)	US20130303487A1 (pl)
EP (2)	EP2849758B1 (pl)
JP (2)	JP2015518828A (pl)
KR (3)	KR20160139050A (pl)
CN (2)	CN104349781A (pl)
AU (3)	AU2013262995B2 (pl)
CA (2)	CA2987470A1 (pl)
CY (1)	CY1120503T1 (pl)
DK (1)	DK2849758T3 (pl)
ES (1)	ES2667535T3 (pl)
HK (1)	HK1255373A1 (pl)
HR (1)	HRP20180606T1 (pl)
HU (1)	HUE038905T2 (pl)
LT (1)	LT2849758T (pl)
NZ (1)	NZ702414A (pl)
PL (1)	PL2849758T3 (pl)
PT (1)	PT2849758T (pl)
RS (1)	RS57294B1 (pl)
SI (1)	SI2849758T1 (pl)
SM (1)	SMT201800212T1 (pl)
WO (1)	WO2013173330A1 (pl)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101813728B1 (ko)	2009-07-31	2017-12-29	그뤼넨탈 게엠베하	결정화 방법 및 생체이용률
US20160016982A1 (en)	2009-07-31	2016-01-21	Thar Pharmaceuticals, Inc.	Crystallization method and bioavailability
WO2012071517A2 (en)	2010-11-24	2012-05-31	Thar Pharmaceuticals, Inc.	Novel crystalline forms
US10016445B2 (en)	2012-05-14	2018-07-10	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9949993B2 (en)	2012-05-14	2018-04-24	Antecip Bioventures Ii Llc	Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9999628B2 (en)	2012-05-14	2018-06-19	Antecip Bioventures Ii Llc	Neridronic acid for treating complex regional pain syndrome
US9789128B2 (en)	2012-05-14	2017-10-17	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9289441B2 (en)	2014-08-08	2016-03-22	Antecip Bioventures Ii Llc	Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US9901589B2 (en)	2012-05-14	2018-02-27	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10413560B2 (en)	2012-05-14	2019-09-17	Antecip Bioventures Ii Llc	Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10463682B2 (en)	2012-05-14	2019-11-05	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US10034890B2 (en)	2012-05-14	2018-07-31	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10173986B2 (en)	2012-05-14	2019-01-08	Antecip Bioventures Ii Llc	Methods for the safe administration of imidazole or imidazolium compounds
US9655908B2 (en)	2012-05-14	2017-05-23	Antecip Bioventures Ii Llc	Neridronic acid molecular complex for treating complex regional pain syndrome
US10080765B2 (en)	2012-05-14	2018-09-25	Antecip Bioventures Ii Llc	Neridronic acid for treating complex regional pain syndrome
US10493085B2 (en)	2012-05-14	2019-12-03	Antecip Bioventures Ii Llc	Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US9943531B2 (en)	2014-08-08	2018-04-17	Antecip Bioventures Ii Llc	Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US9956238B2 (en)	2014-05-15	2018-05-01	Antecip Bioventures Ii Llc	Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10039773B2 (en)	2012-05-14	2018-08-07	Antecip Bioventures Ii Llc	Neridronic acid for treating arthritis
US10028908B2 (en)	2012-05-14	2018-07-24	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10111837B2 (en)	2012-05-14	2018-10-30	Antecip Bioventures Ii Llc	Dosage forms for oral administration of zoledronic acid or related compounds
US9700570B2 (en)	2014-05-27	2017-07-11	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
WO2015184003A1 (en) *	2014-05-27	2015-12-03	Antecip Bioventures Ii Llp	Osteoclast inhibitors for pain
US9956234B2 (en)	2012-05-14	2018-05-01	Antecip Bioventures Ii Llc	Osteoclast inhibitors for joint conditions
US9895383B2 (en)	2012-05-14	2018-02-20	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9427403B2 (en)	2012-05-14	2016-08-30	Antecip Bioventures Ii Llc	Methods for the safe administration of imidazole or imidazolium compounds
US20140349974A1 (en) *	2014-08-12	2014-11-27	Antecip Bioventures Ii Llc	Zoledronic acid dosage forms for the treatment of pain
US10092581B2 (en)	2014-05-15	2018-10-09	Antecip Bioventures Ii Llc	Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US9956237B2 (en)	2012-05-14	2018-05-01	Antecip Bioventures Ii Llc	Osteoclast inhibitors for knee conditions
US9861648B2 (en)	2012-05-14	2018-01-09	Antecip Boiventures Ii Llc	Osteoclast inhibitors for knee conditions
US9675626B2 (en)	2012-05-14	2017-06-13	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9827256B2 (en)	2014-05-27	2017-11-28	Antecip Bioventures Ii Llc	Compositions for administration of zoledronic acid or related compounds for treating lower back pain
US9694023B2 (en)	2012-05-14	2017-07-04	Antecip Bioventures Ii Llc	Methods for the safe administration of imidazole or imidazolium compounds
US9999629B2 (en)	2012-05-14	2018-06-19	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10413561B2 (en)	2012-05-14	2019-09-17	Antecip Bioventures Ii Llc	Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US8802658B2 (en) *	2012-05-14	2014-08-12	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating disease
US11654152B2 (en)	2012-05-14	2023-05-23	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating disease
US9616078B2 (en)	2012-05-14	2017-04-11	Antecip Bioventures Ii Llc	Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10028969B2 (en)	2012-05-14	2018-07-24	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9925203B2 (en)	2012-05-14	2018-03-27	Antecip Bioventures Ii Llc	Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9717747B2 (en)	2012-05-14	2017-08-01	Antecip Bioventures Ii Llc	Osteoclast inhibitors for knee conditions
US9867840B2 (en)	2014-05-27	2018-01-16	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9211257B2 (en)	2012-05-14	2015-12-15	Antecip Bioventures Ii Llc	Osteoclast inhibitors for knee conditions
US9795622B2 (en)	2012-05-14	2017-10-24	Antecip Bioventures Ii Llc	Neridronic acid for treating pain associated with a joint
US9867839B2 (en)	2012-05-14	2018-01-16	Antecip Bioventures Ii Llc	Osteoclast inhibitors for joint conditions
US9782421B1 (en)	2012-05-14	2017-10-10	Antecip Bioventures Ii Llc	Neridronic acid molecular complex for treating complex regional pain syndrome
US9877977B2 (en)	2012-05-14	2018-01-30	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10016446B2 (en)	2012-05-14	2018-07-10	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
US9844559B2 (en)	2012-05-14	2017-12-19	Antecip Bioventures Ii Llc	Neridronic acid for treating bone marrow lesions
US9707247B2 (en)	2012-05-14	2017-07-18	Antecip Bioventures Ii Llc	Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9827192B2 (en)	2012-05-14	2017-11-28	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9669040B2 (en)	2012-05-14	2017-06-06	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9820999B2 (en)	2012-05-14	2017-11-21	Antecip Bioventures Ii Llc	Neridronic acid for treating complex regional pain syndrome
US10004756B2 (en)	2014-05-15	2018-06-26	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US8865757B1 (en)	2014-05-28	2014-10-21	Antecip Bioventures Ii Llp	Therapeutic compositions comprising imidazole and imidazolium compounds
US9770457B2 (en)	2012-05-14	2017-09-26	Antecip Bioventures Ii Llc	Neridronic acid for treating bone marrow lesion
US9662343B2 (en)	2012-05-14	2017-05-30	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9707245B2 (en)	2012-05-14	2017-07-18	Antecip Bioventures Ii Llc	Neridronic acid for treating complex regional pain syndrome
US10350227B2 (en)	2012-05-14	2019-07-16	Antecip Bioventures Ii Llc	Neridronic acid for treating complex regional pain syndrome
CN104969556A (zh)	2013-01-08	2015-10-07	Lg电子株式会社	处理视频信号的方法和设备
KR101739244B1 (ko) *	2013-10-25	2017-05-23	안테씨프 바이오벤쳐스 투 엘엘씨	질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
US20170182072A1 (en) *	2014-05-27	2017-06-29	Antecip Bioventures Ii Llc	Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
MY185481A (en) *	2014-05-27	2021-05-19	Antecip Bioventures Ii Llc	Osteoclast inhibitors for pain
NZ726690A (en) *	2014-05-27	2018-03-23	Antecip Bioventures Ii Llc	Osteoclast inhibitors for pain
US9127069B1 (en)	2014-06-11	2015-09-08	Antecip Bioventures LLC	Compositions comprising rank/rankl antagonists and related compounds for treating pain
US9079927B1 (en)	2014-05-27	2015-07-14	Antecip Bioventures Ii Llc	Substituted imidazolium compounds for treating disease
US9688765B2 (en)	2014-06-11	2017-06-27	Antecip Bioventures Ii Llc	Methods using RANK/RANKL antagonist antibodies for treating pain
SG11201702574XA (en) *	2014-10-15	2017-04-27	Abiogen Pharma Spa	Use of neridronic acid or of its salt for the treatment of osteoarthrosis
MX2018002627A (es) *	2015-09-18	2018-12-17	Gruenenthal Chemie	Metodo de cristalizacion y biodisponibilidad.
WO2017208070A1 (en)	2016-05-31	2017-12-07	Grünenthal GmbH	Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis
US20190328755A1 (en) *	2018-04-30	2019-10-31	Grunenthal Gmbh	Methods of treating complex regional pain syndrome (crps) or symptoms comprising administration of neridronic acid
CN109908159B (zh) *	2019-03-15	2021-12-07	暨南大学	唑来膦酸和有机硒化合物联用在制备抗肿瘤药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4639338A (en) *	1984-08-06	1987-01-27	Ciba-Geigy Corporation	Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US6579860B1 (en) *	1998-12-25	2003-06-17	Toray Industries, Inc.	Interleukin-6 production inhibitors
GB0029111D0 (en) *	2000-11-29	2001-01-10	Novartis Ag	Organic compounds
CA2478317A1 (en) *	2002-03-04	2003-09-18	Medimmune, Inc.	Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
US7875597B2 (en) *	2002-07-24	2011-01-25	New York University	Treatment of spinal mechanical pain
AU2003280373A1 (en) *	2002-10-15	2004-05-04	Novartis Ag	Method of administering bisphosphonates
ES2322592T3 (es) *	2003-07-03	2009-06-23	Teva Pharmaceutical Industries Ltd.	Formas cristalinas de acido zoledronico, formas cristlinas de la sal sodica de zoledronato, sal sodica de zoledronato amorfa y procedimientos para su preparacion.
AR046773A1 (es) *	2003-12-23	2005-12-21	Novartis Ag	Formulaciones farmaceuticas de bisfosfonatos
WO2005072747A1 (ja) *	2004-02-02	2005-08-11	Ono Pharmaceutical Co., Ltd.	骨吸収抑制剤
CA2563335A1 (en) *	2004-04-16	2005-12-08	Emisphere Technologies, Inc.	8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
CA2565079A1 (en) *	2004-05-06	2005-11-17	Merck & Co., Inc.	Methods for treating arthritic conditions in dogs
KR20080083068A (ko) *	2004-05-24	2008-09-12	더 프록터 앤드 갬블 캄파니	킬레이팅제를 함유하는 비스포스포네이트의 고형의 장용 경구 투여 형태
WO2006102117A1 (en) *	2005-03-17	2006-09-28	Elan Pharma International Limited	Nanoparticulate biphosphonate compositions
BRPI0710503A2 (pt) *	2006-04-07	2011-08-16	Merrion Res Iii Ltd	uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
TWI480286B (zh) *	2009-02-25	2015-04-11	Merrion Res Iii Ltd	雙膦酸鹽類組合物及藥物遞送
WO2011014781A1 (en) *	2009-07-31	2011-02-03	Thar Pharmaceuticals, Inc.	Novel oral forms of a phosphonic acid derivative
EP2531200B1 (en) *	2010-02-06	2017-07-12	Grünenthal GmbH	Crystallization method and bioavailability

2013
- 2013-05-14 PL PL13791356T patent/PL2849758T3/pl unknown
- 2013-05-14 KR KR1020167032879A patent/KR20160139050A/ko not_active Ceased
- 2013-05-14 NZ NZ702414A patent/NZ702414A/en unknown
- 2013-05-14 SI SI201330993T patent/SI2849758T1/en unknown
- 2013-05-14 AU AU2013262995A patent/AU2013262995B2/en active Active
- 2013-05-14 CA CA2987470A patent/CA2987470A1/en not_active Abandoned
- 2013-05-14 US US13/894,262 patent/US20130303487A1/en not_active Abandoned
- 2013-05-14 CA CA2873742A patent/CA2873742C/en active Active
- 2013-05-14 KR KR1020197000076A patent/KR20190004381A/ko not_active Ceased
- 2013-05-14 DK DK13791356.2T patent/DK2849758T3/en active
- 2013-05-14 US US13/894,274 patent/US20130303488A1/en not_active Abandoned
- 2013-05-14 SM SM20180212T patent/SMT201800212T1/it unknown
- 2013-05-14 US US13/894,252 patent/US20130303486A1/en not_active Abandoned
- 2013-05-14 HU HUE13791356A patent/HUE038905T2/hu unknown
- 2013-05-14 PT PT137913562T patent/PT2849758T/pt unknown
- 2013-05-14 US US13/894,244 patent/US20130303485A1/en not_active Abandoned
- 2013-05-14 EP EP13791356.2A patent/EP2849758B1/en active Active
- 2013-05-14 KR KR1020147034760A patent/KR20150035597A/ko not_active Ceased
- 2013-05-14 WO PCT/US2013/040939 patent/WO2013173330A1/en not_active Ceased
- 2013-05-14 ES ES13791356.2T patent/ES2667535T3/es active Active
- 2013-05-14 JP JP2015512753A patent/JP2015518828A/ja active Pending
- 2013-05-14 EP EP17206293.7A patent/EP3323418A1/en not_active Withdrawn
- 2013-05-14 HR HRP20180606TT patent/HRP20180606T1/hr unknown
- 2013-05-14 RS RS20180483A patent/RS57294B1/sr unknown
- 2013-05-14 LT LTEP13791356.2T patent/LT2849758T/lt unknown
- 2013-05-14 CN CN201380025570.XA patent/CN104349781A/zh active Pending
- 2013-05-14 CN CN201811173434.6A patent/CN109331027A/zh active Pending
2016
- 2016-02-03 US US15/014,994 patent/US20160151398A1/en not_active Abandoned
- 2016-11-08 AU AU2016256701A patent/AU2016256701B2/en active Active
2018
- 2018-04-11 JP JP2018075822A patent/JP2018127477A/ja active Pending
- 2018-05-03 CY CY20181100458T patent/CY1120503T1/el unknown
- 2018-08-10 AU AU2018214132A patent/AU2018214132B2/en active Active
- 2018-11-14 HK HK18114512.0A patent/HK1255373A1/en unknown

Also Published As

Publication number	Publication date
PT2849758T (pt)	2018-05-09
EP2849758A4 (en)	2015-12-30
NZ702414A (en)	2016-10-28
AU2018214132B2 (en)	2019-07-11
AU2016256701A1 (en)	2016-11-24
CA2873742C (en)	2018-01-16
JP2015518828A (ja)	2015-07-06
AU2016256701B2 (en)	2018-05-10
KR20150035597A (ko)	2015-04-06
KR20190004381A (ko)	2019-01-11
SI2849758T1 (en)	2018-07-31
US20130303487A1 (en)	2013-11-14
CA2987470A1 (en)	2013-11-21
HRP20180606T1 (hr)	2018-06-29
EP3323418A1 (en)	2018-05-23
DK2849758T3 (en)	2018-05-14
US20130303485A1 (en)	2013-11-14
CN104349781A (zh)	2015-02-11
KR20160139050A (ko)	2016-12-06
CN109331027A (zh)	2019-02-15
AU2018214132A1 (en)	2018-08-30
US20130303486A1 (en)	2013-11-14
US20130303488A1 (en)	2013-11-14
LT2849758T (lt)	2018-07-25
RS57294B1 (sr)	2018-08-31
AU2013262995A1 (en)	2014-12-18
JP2018127477A (ja)	2018-08-16
AU2013262995B2 (en)	2016-09-01
HK1255373A1 (en)	2019-08-16
US20160151398A1 (en)	2016-06-02
HUE038905T2 (hu)	2018-12-28
SMT201800212T1 (it)	2018-07-17
WO2013173330A1 (en)	2013-11-21
EP2849758B1 (en)	2018-04-04
ES2667535T3 (es)	2018-05-11
CA2873742A1 (en)	2013-11-21
CY1120503T1 (el)	2019-07-10
EP2849758A1 (en)	2015-03-25

Publication	Publication Date	Title
LT2849758T (lt)	2018-07-25	Kompozicijos, apimančios zoledrono rūgštį arba susijusius junginius, skirtos palengvinti uždegiminį skausmą ir susijusias būkles
ZA202101713B (en)	2022-07-27	Low volatility herbicidal compositions
IL266582A (en)	2019-07-31	Preparations and methods for the treatment of hemoglobin diseases
ME03042B (me)	2018-10-20	Jedinjenja i kompozicije za tretman parazitskih oboljenja
GB2511713B (en)	2020-03-04	Compositions for the treatment of bone fragility
ZA201307793B (en)	2015-04-29	Novel compound useful for the treatment of degenerative and inflammatory diseases
LT2867218T (lt)	2017-04-25	Dimetilbenzoinės rūgšties junginiai, tinkami uždegiminių būklių gydymui
IL229079A (en)	2017-12-31	Preparations containing pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
IL234829A0 (en)	2014-12-31	Methods and preparations for treating inflammation
PL2552449T3 (pl)	2017-09-29	Kompozycje zawierające brymonidynę do leczenia rumienia
ZA201408056B (en)	2016-04-28	Compositions and methods for the treatment of mucositis
ZA201408055B (en)	2016-03-30	Compositions and methods for the treatment of local pain
PL2860211T3 (pl)	2019-12-31	Preparaty estrów kwasu fosforowego o obniżonej higroskopijności
EP2897630A4 (en)	2016-06-08	ANTI-INFLAMMATORY COMPOSITIONS FOR THE TREATMENT OF NEUROGENIC INFLAMMATION
ZA201500111B (en)	2016-01-27	Compositions and methods for enhancing the efficacy of contraceptive microbicides
GB201210397D0 (en)	2012-07-25	Crop enhancement compositions
ZA201408057B (en)	2016-03-30	Compositions and methods for the treatment of moderate to severe pain
ZA201408058B (en)	2016-03-30	Compositions and methods for the treatment of epilepsy
IL223385B (en)	2020-06-30	Treatment of inflammatory disorders
ZA201408045B (en)	2016-03-30	Compositions and methods for the treatment of inflammation and lipid disorders
GB201210395D0 (en)	2012-07-25	Crop enhancement compositions
PT2538922T (pt)	2016-07-11	Formulação de composições para o tratamento de doenças inflamatórias
ZA201303790B (en)	2014-04-30	Formulation useful for treating pain and/or inflammation
GB201201779D0 (en)	2012-03-14	Treatment of inflammatory disorders
GB201002842D0 (en)	2010-04-07	Treatment of inflammatory disorders